SantoSolve Overview

  • Year Founded
  • 1994

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Out of Business

SantoSolve General Information

Description

Developer of analgesic products intended to mitigate the adverse effects and health risks associated with existing pain drugs. The company's products are based on non-radioactive strontium and focus on pain treatment and inflammatory lesions, enabling patients to avail of a pharmaceutical formulation for the treatment of local and neuropathic pain conditions.

Contact Information

Website
www.santosolve.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Enebakkveien 117A
  • 0680 Oslo
  • Norway
+47 21
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • Enebakkveien 117A
  • 0680 Oslo
  • Norway
+47 21

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SantoSolve Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 01-Feb-2021 Completed Out of Business
6. Secondary Transaction - Private 01-Apr-2015 Completed Clinical Trials - Phase 3
5. Secondary Transaction - Private 01-Jun-2012 Completed Clinical Trials - Phase 3
4. Later Stage VC (Series C) 26-Sep-2009 Completed Clinical Trials - Phase 3
3. Later Stage VC 28-Nov-2008 Completed Generating Revenue
2. Later Stage VC 07-Nov-2007 $7M $7M Completed Generating Revenue
1. Later Stage VC 01-Jan-2004 Completed Generating Revenue
To view SantoSolve’s complete valuation and funding history, request access »

SantoSolve Patents

  • 32

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

SantoSolve Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1834541-A1 Applicator, use of the applicator and method for topically administering a liquid by means of the applicator Inactive 14-Mar-2006
US-20090092438-A1 Applicator, use of the applicator and method for topically administering a liquid by means of the applicator Inactive 14-Mar-2006
WO-2007105161-A2 Applicator, use of the applicator and method for topically administering a liquid by means of the applicator Inactive 14-Mar-2006
WO-2007105161-A3 Applicator, use of the applicator and method for topically administering a liquid by means of the applicator Inactive 14-Mar-2006
WO-2007060381-A1 Strontium-containing compositions and their use in methods of cosmetic treatment Inactive 24-Nov-2005 A61K8/19
To view SantoSolve’s complete patent history, request access »

SantoSolve Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

SantoSolve FAQs

  • When was SantoSolve founded?

    SantoSolve was founded in 1994.

  • Where is SantoSolve headquartered?

    SantoSolve is headquartered in Oslo, Norway.

  • What is the size of SantoSolve?

    SantoSolve has 8 total employees.

  • What industry is SantoSolve in?

    SantoSolve’s primary industry is Drug Discovery.

  • Is SantoSolve a private or public company?

    SantoSolve is a Private company.

  • What is SantoSolve’s current revenue?

    The current revenue for SantoSolve is .

  • How much funding has SantoSolve raised over time?

    SantoSolve has raised $12.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process